DNA Brands is trading at 1.0E-4 as of the 25th of November 2024; that is 50 percent decrease since the beginning of the trading day. The stock's open price was 2.0E-4. DNA Brands has about a 39 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for DNA Brands are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.
It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. Dna Brands operates under BeveragesNon-Alcoholic classification in the United States and is traded on OTC Exchange. The company has 22.07 K outstanding shares. More on DNA Brands
DNA Brands [DNAX] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 33.98 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DNA Brands's market, we take the total number of its shares issued and multiply it by DNA Brands's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DNA Brands conducts business under Beverages sector and is part of Consumer Staples industry. The entity has 22.07 K outstanding shares.
DNA Brands currently holds about 499 in cash with (1.1 M) of positive cash flow from operations.
Check DNA Brands Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in DNA Brands without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Optimization Now
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.